Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study-Reference-Cited by-同舟云学术

Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study

Published:2020-03 Issue:3 Volume:26 Page:472-479
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

DeFilipp Zachariah,Ancheta Richard,Liu Ying,Hu Zhen-Huan^ORCID,Gale Robert Peter,Snyder David,Schouten Harry C.,Kalaycio Matt,Hildebrandt Gerhard C.,Ustun Celalettin,Daly Andrew,Ganguly Siddhartha,Inamoto Yoshihiro,Litzow Mark,Szer Jeffrey,Savoie Mary Lynn,Hossain Nasheed^ORCID,Kharfan-Dabaja Mohamed A.,Hamadani Mehdi,Reshef Ran,Bajel Ashish,Schultz Kirk R.,Gadalla Shahinaz,Gerds Aaron,Liesveld Jane,Juckett Mark B.,Kamble Rammurti,Hashmi Shahrukh,Abdel-Azim Hisham,Solh Melhem,Bacher Ulrike,Lazarus Hillard,Olsson Richard^ORCID,Cahn Jean-Yves,Grunwald Michael R.,Savani Bipin N.,Yared Jean,Rowe Jacob M.,Cerny Jan^ORCID,Chaudhri Naeem A.,Aljurf Mahmoud,Beitinjaneh Amer,Seo Sachiko,Nishihori Taiga,Hsu Jack W.,Ramanathan Muthalagu,Alyea Edwin,Popat Uday,Sobecks Ronald,Saber Wael^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference15 articles.

1. Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008;Björkholm;J Clin Oncol,2011

2. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience;Kantarjian;Blood,2012

3. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013;Baccarani;Blood,2013

4. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis;Khoury;Bone Marrow Transplant,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia;American Journal of Hematology;2024-05-28

2. Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML;Blood Advances;2024-02-16

3. Stem cell allografting for chronic Myeloid leukemia in the tyrosine kinase era – forgotten but not gone;Leukemia & Lymphoma;2024-02-09

4. Myeloproliferative Neoplasms;The EBMT Handbook;2024

5. Allogeneic Cell Transplantation for Myeloproliferative Neoplasms;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024